title: Rimonabant in obese patients with type 2 diabetes.
authors.forename: Michael D
authors.initials: MD
authors.lastname: Randall
authors.forename: David A
authors.initials: DA
authors.lastname: Kendall
authors.forename: Andrew J
authors.initials: AJ
authors.lastname: Bennett
authors.forename: Saoirse E
authors.initials: SE
authors.lastname: O'Sullivan
mesh_terms: D063387:Cannabinoid Receptor Antagonists; D003924:Diabetes Mellitus, Type 2 / Q000150:complications; D006801:Humans; D009765:Obesity / Q000150:complications / Q000188:drug therapy*; D047495:PPAR gamma / Q000187:drug effects*; D010880:Piperidines / Q000494:pharmacology / Q000627:therapeutic use*; D011720:Pyrazoles / Q000494:pharmacology / Q000627:therapeutic use*; D000077285:Rimonabant; D015431:Weight Loss / Q000187:drug effects
chemical_list: D063387:Cannabinoid Receptor Antagonists; D047495:PPAR gamma; D010880:Piperidines; D011720:Pyrazoles; D000077285:Rimonabant